Select Page

Infinium Global Research has added a new report on Narcolepsy Treatment Market. The report covers the analysis of global as well as regional markets of narcolepsy treatment. Moreover, the report gives insights into the factors that affect the global as well as regional performance of the market in the short run and in the long run. According to the report, the global narcolepsy treatment market is projected to grow at a CAGR of 7.8% over the forecast period of 2019-2025.

For More Details Get FREE Sample Pages of this Research Report@

Narcolepsy is a neurological disorder characterized by excessive daytime sleepiness, sleep paralysis, disrupted nighttime sleep, hallucinations, and in some cases episodes of cataplexy. Narcolepsy occurs equally in women and men and is assumed to affect roughly 1 in 2,000 people. Generally, narcolepsy begins between the ages of 15 and 25, but it can become actual at any age. Narcolepsy is identified by taking a medical history, physical exam as well as conducting sleep studies. There are three approaches to the treatment of narcolepsy includes modern medications, lifestyle adjustments, and complementary therapy.

Narcolepsy Treatment Market has Driven by Increasing Prevalence’s of Narcolepsy Due to a Surge in Stress Levels and Unhealthy Lifestyle

The global narcolepsy treatment market has driven by increasing prevalence’s of narcolepsy due to a surge in stress levels and unhealthy lifestyle. As per the narcolepsy network, it is estimated that only 25% of people who have narcolepsy have been diagnosed and are receiving treatment. Furthermore, growing research and development activities to find a cure for narcolepsy is another factor augments the growth of narcolepsy treatment market. Additionally, increasing demand for advanced therapies for sleeping disorder coupled with rising health care expenditure and reimbursement policies is escalating the growth of the narcolepsy treatment market during the forecast period. However, low awareness among patients about narcolepsy treatment in developing countries is likely to hamper the growth of the global narcolepsy treatment market.

North America Held a Maximum Share in the Global Narcolepsy Treatment Market

Geographically, the global narcolepsy treatment market is bifurcated into North America, Europe, Asia Pacific, and RoW. North America held a maximum share in the global narcolepsy treatment market. This is due to well-developed infrastructures coupled with rising awareness about the narcolepsy treatment. Moreover, Europe is also anticipated to contribute a significant share in this market due to a rise in R&D activities. Furthermore, the Asia Pacific region is projected to witness the fastest growth rate during the forecast period. The factors such as growing focus on healthcare expenditures, occurrences of lifestyle-related diseases increased investment in the pharmaceutical sector coupled with growth in awareness about health.

Narcolepsy Treatment Market: Segmentation

The report on global narcolepsy treatment market covers segments such as drug class, narcolepsy type, and end-user. On the basis of drug class, the sub-markets include vasopressors, CNS stimulants, decongestants, and serotonin reuptake inhibitors. On the basis of narcolepsy type, the sub-markets include narcolepsy type 1, and narcolepsy type 2. On the basis of end-user, the sub-markets include retail pharmacies, drug stores, and e-commerce.

Narcolepsy Treatment Market: Competitive Landscape

The report provides profiles of the companies in the market such as Ligand Pharmaceuticals, Shire Plc, Teva Pharmaceutical Industries Ltd., Graymark Healthcare Inc., Arena Pharmaceuticals, Inc., Jazz Pharmaceuticals plc, and Other Companies.

Browse Detailed TOC and Description of this Exclusive Report@

Reasons to Buy this Report:

  • Comprehensive analysis of global as well as regional markets of the Narcolepsy Treatment.
  • Complete coverage of all the product type and applications segments to analyze the trends, developments, and forecast of market size up to 2025.
  • Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.
  • Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.